TREATMENT OF ADVANCED BREAST-CANCER WITH 20 MG TOREMIFENE, A PHASE-II STUDY - PRELIMINARY COMMUNICATION

被引：8
|
作者：
PYRHONEN, S
VALAVAARA, R
HEIKKINEN, M
RISSANEN, P
BLANCO, G
NORDMAN, E
HOLSTI, LR
HAJBA, A
机构：
[1] FARMOS GRP LTD,RES CTR,TURKU,FINLAND
[2] UNIV TURKU,CENT HOSP,DEPT RADIOTHERAPY & ONCOL,SF-20500 TURKU 50,FINLAND
[3] UNIV OULU,CENT HOSP,SF-90220 OULU 22,FINLAND
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90011-G
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Fourteen postmenopausal women with estrogen-receptor positive advanced breast cancer and no prior cytostatic treatment received 20 mg toremifene daily as a single dose after a loading dose (120→60→60 mg) for the first 3 days. All were evaluable and had undergone at least 6 weeks' treatment. Results were: no complete remissions (CR), 3 partial remissions (PR), 8 no change (NC) and 3 cases of progressive disease (PD). Three patients had mild side effects: nausea, insomnia, sweating and arm pain. © 1990.
引用
收藏
页码：227 / 228
页数：2
相关论文
共 50 条
  • [1] TOREMIFENE, A NEW ANTIESTROGENIC COMPOUND, FOR TREATMENT OF ADVANCED BREAST-CANCER - PHASE-II STUDY
    VALAVAARA, R
    PYRHONEN, S
    HEIKKINEN, M
    RISSANEN, P
    BLANCO, G
    THOLIX, E
    NORDMAN, E
    TASKINEN, P
    HOLSTI, L
    HAJBA, A
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 785 - 790
  • [2] PHASE-II CLINICAL-STUDY OF TOREMIFENE IN PATIENTS WITH METASTATIC BREAST-CANCER - PRELIMINARY COMMUNICATION
    MODIG, H
    BORGSTROM, S
    NILSSON, I
    WESTMAN, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 235 - 236
  • [3] PHASE-II TRIALS WITH TOREMIFENE IN ADVANCED BREAST-CANCER - A REVIEW
    VALAVAARA, R
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 : S31 - S35
  • [4] PHASE-II STUDY OF HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER PROGRESSING DURING TAMOXIFENE TREATMENT
    JONSSON, PE
    MALMBERG, M
    BERGLJUNG, L
    INGVAR, C
    ERICSSON, M
    RYDEN, S
    NILSSON, I
    TERJE, IJ
    ANTICANCER RESEARCH, 1991, 11 (02) : 873 - 876
  • [5] SAFETY AND EFFICACY OF TOREMIFENE IN BREAST-CANCER PATIENTS - A PHASE-II STUDY
    VALAVAARA, R
    PYRHONEN, S
    HEIKKINEN, M
    RISSANEN, P
    BLANCO, G
    NORDMAN, E
    TASKINEN, P
    HOLSTI, LR
    HAJBA, A
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 229 - 231
  • [6] PEPLOMYCIN IN TREATMENT OF ADVANCED METASTATIC BREAST-CANCER - A PHASE-II STUDY
    BUZDAR, A
    ESPARZA, L
    BLUMENSCHEIN, G
    HORTOBAGYI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 165 - 165
  • [7] PEPTICHEMIO IN TREATMENT OF ADVANCED REFRACTORY BREAST-CANCER - PHASE-II STUDY
    BUZDAR, AU
    LEGHA, SS
    HORTOBAGYI, GN
    BODEY, GP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 174 - 174
  • [8] ELLIPTINIUM ACETATE IN TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II STUDY
    BUZDAR, AU
    ESPARZA, L
    HORTOBAGYI, GN
    LICHTIGER, B
    HOLMES, FA
    HUG, V
    FRASCHINI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 200 - 200
  • [9] PHASE-II STUDY OF CARBOPLATIN IN ADVANCED BREAST-CANCER - PRELIMINARY-RESULTS
    MARTIN, M
    DIAZRUBIO, E
    CASADO, A
    VEGA, JML
    SEMINARS IN ONCOLOGY, 1991, 18 (01) : 23 - 27
  • [10] PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER
    MODIG, H
    BORGSTROM, S
    NILSSON, I
    WESTMAN, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03): : 237 - 238
12345